Dasa LIPOVSEK

Person

Cambridge, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
PD-L1 binding polypeptides for imaging
- Patent number 12,194,110
- Issue date Jan 14, 2025
- Bristol-Myers Squibb Company
- Paul E. Morin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of fibrosis, cardiovascular disease and heart failure wit...
- Patent number 12,097,242
- Issue date Sep 24, 2024
- Bristol-Myers Squibb Company
- Gene M. Dubowchik
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating kidney failure, and/or improving or stablizing...
- Patent number 12,097,241
- Issue date Sep 24, 2024
- Bristol-Myers Squibb Company
- Gene M. Dubowchik
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for the selection of binding proteins
- Patent number 11,913,137
- Issue date Feb 27, 2024
- Bristol-Myers Squibb Company
- Dasa Lipovsek
- C40 - COMBINATORIAL CHEMISTRY
Information Patent Grant
Fibronectin based scaffold domain proteins that bind PCSK9
- Patent number 11,858,979
- Issue date Jan 2, 2024
- Bristol-Meyers Squibb Company
- Ray Camphausen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Fibronectin based scaffold domain proteins that bind to myostatin
- Patent number 11,813,315
- Issue date Nov 14, 2023
- Bristol-Myers Squibb Company
- Sharon Cload
- G01 - MEASURING TESTING
Information Patent Grant
Glypican-3-binding fibronectin based scaffold molecules
- Patent number 11,524,992
- Issue date Dec 13, 2022
- Bristol-Myers Squibb Company
- Dasa Lipovsek
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fibronectin based scaffold proteins
- Patent number 11,447,538
- Issue date Sep 20, 2022
- Bristol-Myers Squibb Company
- Dasa Lipovsek
- G01 - MEASURING TESTING
Information Patent Grant
Fast-off rate serum albumin binding fibronectin type III domains
- Patent number 11,434,275
- Issue date Sep 6, 2022
- Bristol-Myers Squibb Company
- Stanley Richard Krystek
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fibronectin binding domains with reduced immunogenicity
- Patent number 11,408,093
- Issue date Aug 9, 2022
- Bristol-Myers Squibb Company
- Jonathan Davis
- C40 - COMBINATORIAL CHEMISTRY
Information Patent Grant
Stabilized fibronectin based scaffold molecules
- Patent number 11,407,815
- Issue date Aug 9, 2022
- Bristol-Myers Squibb Company
- Dasa Lipovsek
- C40 - COMBINATORIAL CHEMISTRY
Information Patent Grant
Modified relaxin polypeptides comprising a pharmacokinetic enhancer...
- Patent number 11,364,281
- Issue date Jun 21, 2022
- Bristol-Myers Squibb Company
- Gene M. Dubowchik
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
PET imaging with PD-L1 binding polypeptides
- Patent number 11,344,639
- Issue date May 31, 2022
- Bristol-Myers Squibb Company
- Paul E. Morin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fibronectin binding domains with reduced immunogenicity
- Patent number 11,279,751
- Issue date Mar 22, 2022
- Bristol-Myers Squibb Company
- Jonathan Davis
- C40 - COMBINATORIAL CHEMISTRY
Information Patent Grant
Methods of treating diseases associated with fibrosis using modifie...
- Patent number 11,248,031
- Issue date Feb 15, 2022
- Bristol-Myers Squibb Company
- Paul E. Morin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Modified relaxin polypeptides comprising a pharmacokinetic enhancer...
- Patent number 11,224,634
- Issue date Jan 18, 2022
- Bristol-Myers Squibb Company
- Gene M. Dubowchik
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Serum albumin-binding fibronectin type III domains
- Patent number 11,203,630
- Issue date Dec 21, 2021
- Bristol-Myers Squibb Company
- Tracy S. Mitchell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of treating cardiovascular disease and heart failure with mo...
- Patent number 11,185,570
- Issue date Nov 30, 2021
- Bristol-Myers Squibb Company
- Gene M. Dubowchik
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
PD-L1 binding polypeptides for imaging
- Patent number 11,173,219
- Issue date Nov 16, 2021
- Bristol-Myers Squibb Company
- Paul E. Morin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for the selection of binding proteins
- Patent number 11,060,085
- Issue date Jul 13, 2021
- Bristol-Myers Squibb Company
- Dasa Lipovsek
- C40 - COMBINATORIAL CHEMISTRY
Information Patent Grant
Fibronectin based scaffold domain proteins that bind PCSK9
- Patent number 10,947,297
- Issue date Mar 16, 2021
- Bristol-Myers Squibb Company
- Ray Camphausen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fast-off rate serum albumin binding fibronectin type III domains
- Patent number 10,766,946
- Issue date Sep 8, 2020
- Bristol-Myers Squibb Company
- Stanley Richard Krystek
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fibronectin binding domains with reduced immunogenicity
- Patent number 10,604,556
- Issue date Mar 31, 2020
- Bristol-Myers Squibb Company
- Jonathan Davis
- C40 - COMBINATORIAL CHEMISTRY
Information Patent Grant
Glypican-3-binding fibronectin based scaffold molecules
- Patent number 10,584,160
- Issue date Mar 10, 2020
- Bristol-Myers Squibb Company
- Dasa Lipovsek
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fibronectin binding domains with reduced immunogenicity
- Patent number 10,464,995
- Issue date Nov 5, 2019
- Bristol-Myers Squibb Company
- Jonathan Davis
- C40 - COMBINATORIAL CHEMISTRY
Information Patent Grant
Stabilized fibronectin based scaffold molecules
- Patent number 10,450,363
- Issue date Oct 22, 2019
- Bristol-Myers Squibb Company
- Dasa Lipovsek
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Serum albumin-binding fibronectin type III domains
- Patent number 10,442,851
- Issue date Oct 15, 2019
- Bristol-Myers Squibb Company
- Tracy S. Mitchell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
PD-L1 binding polypeptides for imaging
- Patent number 10,406,251
- Issue date Sep 10, 2019
- Bristol-Myers Squibb Company
- Paul E. Morin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fibronectin based scaffold domain proteins that bind to myostatin
- Patent number 10,406,212
- Issue date Sep 10, 2019
- Bristol-Myers Squibb Company
- Sharon Cload
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating diseases associated with fibrosis using modifie...
- Patent number 10,377,806
- Issue date Aug 13, 2019
- Bristol-Myers Squibb Company
- Paul E. Morin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS THAT BIND TO MYOSTATIN
- Publication number 20240316161
- Publication date Sep 26, 2024
- Bristol-Myers Squibb Company
- Sharon CLOAD
- G01 - MEASURING TESTING
Information Patent Application
FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS THAT BIND PCSK9
- Publication number 20240239870
- Publication date Jul 18, 2024
- Bristol-Myers Squibb Company
- Ray Camphausen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
GLYPICAN-3-BINDING FIBRONECTIN BASED SCAFFOLD MOLECULES
- Publication number 20230312686
- Publication date Oct 5, 2023
- Bristol-Myers Squibb Company
- Dasa LIPOVSEK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FIBRONECTIN BASED SCAFFOLD PROTEINS
- Publication number 20230242617
- Publication date Aug 3, 2023
- Bristol-Myers Squibb Company
- Dasa Lipovsek
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
STABILIZED FIBRONECTIN BASED SCAFFOLD MOLECULES
- Publication number 20230192812
- Publication date Jun 22, 2023
- Bristol-Myers Squibb Company
- Dasa LIPOVSEK
- C40 - COMBINATORIAL CHEMISTRY
Information Patent Application
FIBRONECTIN BINDING DOMAINS WITH REDUCED IMMUNOGENICITY
- Publication number 20230183885
- Publication date Jun 15, 2023
- Bristol-Myers Squibb Company
- Jonathan DAVIS
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
FAST-OFF RATE SERUM ALBUMIN BINDING FIBRONECTIN TYPE III DOMAINS
- Publication number 20230145413
- Publication date May 11, 2023
- Bristol-Myers Squibb Company
- Stanley Richard KRYSTEK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PET IMAGING WITH PD-L1 BINDING POLYPEPTIDES
- Publication number 20220347324
- Publication date Nov 3, 2022
- Bristol-Myers Squibb Company
- Paul E. MORIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODIFIED RELAXIN POLYPEPTIDES COMPRISING A PHARMACOKINETIC ENHANCER...
- Publication number 20220331402
- Publication date Oct 20, 2022
- Bristol-Myers Squibb Company
- Gene M. DUBOWCHIK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FIBRONECTIN BINDING DOMAINS WITH REDUCED IMMUNOGENICITY
- Publication number 20220275535
- Publication date Sep 1, 2022
- Bristol-Myers Squibb Company
- Jonathan DAVIS
- C40 - COMBINATORIAL CHEMISTRY
Information Patent Application
MODIFIED RELAXIN POLYPEPTIDES COMPRISING A PHARMACOKINETIC ENHANCER...
- Publication number 20220211812
- Publication date Jul 7, 2022
- Bristol-Myers Squibb Company
- Gene M. DUBOWCHIK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SERUM ALBUMIN-BINDING FIBRONECTIN TYPE III DOMAINS
- Publication number 20220204589
- Publication date Jun 30, 2022
- Bristol-Myers Squibb Company
- Tracy S. MITCHELL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods of treating diseases associated with fibrosis using modifie...
- Publication number 20220185856
- Publication date Jun 16, 2022
- Bristol-Myers Squibb Company
- Paul E. MORIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL PD-L1 BINDING POLYPEPTIDES FOR IMAGING
- Publication number 20220001040
- Publication date Jan 6, 2022
- Bristol-Myers Squibb Company
- Paul E. MORIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS FOR THE SELECTION OF BINDING PROTEINS
- Publication number 20210403899
- Publication date Dec 30, 2021
- Bristol-Myers Squibb Company
- Dasa LIPOVSEK
- G01 - MEASURING TESTING
Information Patent Application
FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS THAT BIND PCSK9
- Publication number 20210277089
- Publication date Sep 9, 2021
- Bristol-Myers Squibb Company
- Ray Camphausen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MODIFIED RELAXIN POLYPEPTIDES COMPRISING A PHARMACOKINETIC ENHANCER...
- Publication number 20210196791
- Publication date Jul 1, 2021
- Bristol-Myers Squibb Company
- Gene M. DUBOWCHIK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FIBRONECTIN BINDING DOMAINS WITH REDUCED IMMUNOGENICITY
- Publication number 20200339662
- Publication date Oct 29, 2020
- Bristol-Myers Squibb Company
- Jonathan Davis
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
FAST-OFF RATE SERUM ALBUMIN BINDING FIBRONECTIN TYPE III DOMAINS
- Publication number 20200283505
- Publication date Sep 10, 2020
- Bristol-Myers Squibb Company
- Stanley Richard KRYSTEK
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
GLYPICAN-3-BINDING FIBRONECTIN BASED SCAFFOLD MOLECULES
- Publication number 20200262893
- Publication date Aug 20, 2020
- Bristol-Myers Squibb Company
- Dasa LIPOVSEK
- G01 - MEASURING TESTING
Information Patent Application
FIBRONECTIN BASED SCAFFOLD PROTEINS
- Publication number 20200247873
- Publication date Aug 6, 2020
- Bristol-Myers Squibb Company
- Dasa Lipovsek
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
FIBRONECTIN BINDING DOMAINS WITH REDUCED IMMUNOGENICITY
- Publication number 20200123229
- Publication date Apr 23, 2020
- Bristol-Myers Squibb Company
- Jonathan DAVIS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
STABILIZED FIBRONECTIN BASED SCAFFOLD MOLECULES
- Publication number 20200062824
- Publication date Feb 27, 2020
- Bristol-Myers Squibb Company
- Dasa LIPOVSEK
- C40 - COMBINATORIAL CHEMISTRY
Information Patent Application
SERUM ALBUMIN-BINDING FIBRONECTIN TYPE III DOMAINS
- Publication number 20200048328
- Publication date Feb 13, 2020
- Bristol-Myers Squibb Company
- Tracy S. MITCHELL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Modified FGF-21 Polypeptides and Uses Thereof
- Publication number 20190382460
- Publication date Dec 19, 2019
- Bristol-Myers Squibb Company
- Paul E. MORIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL PD-L1 BINDING POLYPEPTIDES FOR IMAGING
- Publication number 20190343972
- Publication date Nov 14, 2019
- Bristol-Myers Squibb Company
- Paul E. MORIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS FOR THE SELECTION OF BINDING PROTEINS
- Publication number 20190338276
- Publication date Nov 7, 2019
- Bristol-Myers Squibb Company
- Dasa Lipovsek
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS THAT BIND TO MYOSTATIN
- Publication number 20190307855
- Publication date Oct 10, 2019
- Bristol-Myers Squibb Company
- Sharon CLOAD
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODIFIED RELAXIN POLYPEPTIDES COMPRISING A PHARMACOKINETIC ENHANCER...
- Publication number 20190256570
- Publication date Aug 22, 2019
- Bristol-Myers Squibb Company
- Gene M. DUBOWCHIK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PET IMAGING WITH PD-L1 BINDING POLYPEPTIDES
- Publication number 20190184042
- Publication date Jun 20, 2019
- Bristol-Myers Squibb Company
- Paul E. MORIN
- C07 - ORGANIC CHEMISTRY

Dasa LIPOVSEK

Person

Patents Grantslast 30 patents

PD-L1 binding polypeptides for imaging

Treatment of fibrosis, cardiovascular disease and heart failure wit...

Methods of treating kidney failure, and/or improving or stablizing...

Methods for the selection of binding proteins

Fibronectin based scaffold domain proteins that bind PCSK9

Fibronectin based scaffold domain proteins that bind to myostatin

Glypican-3-binding fibronectin based scaffold molecules

Fibronectin based scaffold proteins

Fast-off rate serum albumin binding fibronectin type III domains

Fibronectin binding domains with reduced immunogenicity

Stabilized fibronectin based scaffold molecules

Modified relaxin polypeptides comprising a pharmacokinetic enhancer...

PET imaging with PD-L1 binding polypeptides

Fibronectin binding domains with reduced immunogenicity

Methods of treating diseases associated with fibrosis using modifie...

Modified relaxin polypeptides comprising a pharmacokinetic enhancer...

Serum albumin-binding fibronectin type III domains

Method of treating cardiovascular disease and heart failure with mo...

PD-L1 binding polypeptides for imaging

Methods for the selection of binding proteins

Fibronectin based scaffold domain proteins that bind PCSK9

Fast-off rate serum albumin binding fibronectin type III domains

Fibronectin binding domains with reduced immunogenicity

Glypican-3-binding fibronectin based scaffold molecules

Fibronectin binding domains with reduced immunogenicity

Stabilized fibronectin based scaffold molecules

Serum albumin-binding fibronectin type III domains

PD-L1 binding polypeptides for imaging

Fibronectin based scaffold domain proteins that bind to myostatin

Methods of treating diseases associated with fibrosis using modifie...

Patents Applicationslast 30 patents

FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS THAT BIND TO MYOSTATIN

FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS THAT BIND PCSK9

GLYPICAN-3-BINDING FIBRONECTIN BASED SCAFFOLD MOLECULES

FIBRONECTIN BASED SCAFFOLD PROTEINS

STABILIZED FIBRONECTIN BASED SCAFFOLD MOLECULES

FIBRONECTIN BINDING DOMAINS WITH REDUCED IMMUNOGENICITY

FAST-OFF RATE SERUM ALBUMIN BINDING FIBRONECTIN TYPE III DOMAINS

PET IMAGING WITH PD-L1 BINDING POLYPEPTIDES

MODIFIED RELAXIN POLYPEPTIDES COMPRISING A PHARMACOKINETIC ENHANCER...

FIBRONECTIN BINDING DOMAINS WITH REDUCED IMMUNOGENICITY

MODIFIED RELAXIN POLYPEPTIDES COMPRISING A PHARMACOKINETIC ENHANCER...

SERUM ALBUMIN-BINDING FIBRONECTIN TYPE III DOMAINS

Methods of treating diseases associated with fibrosis using modifie...

NOVEL PD-L1 BINDING POLYPEPTIDES FOR IMAGING

METHODS FOR THE SELECTION OF BINDING PROTEINS

FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS THAT BIND PCSK9

MODIFIED RELAXIN POLYPEPTIDES COMPRISING A PHARMACOKINETIC ENHANCER...

FIBRONECTIN BINDING DOMAINS WITH REDUCED IMMUNOGENICITY

FAST-OFF RATE SERUM ALBUMIN BINDING FIBRONECTIN TYPE III DOMAINS

GLYPICAN-3-BINDING FIBRONECTIN BASED SCAFFOLD MOLECULES

FIBRONECTIN BASED SCAFFOLD PROTEINS

FIBRONECTIN BINDING DOMAINS WITH REDUCED IMMUNOGENICITY

STABILIZED FIBRONECTIN BASED SCAFFOLD MOLECULES

SERUM ALBUMIN-BINDING FIBRONECTIN TYPE III DOMAINS

Modified FGF-21 Polypeptides and Uses Thereof

NOVEL PD-L1 BINDING POLYPEPTIDES FOR IMAGING

METHODS FOR THE SELECTION OF BINDING PROTEINS

FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS THAT BIND TO MYOSTATIN

MODIFIED RELAXIN POLYPEPTIDES COMPRISING A PHARMACOKINETIC ENHANCER...

PET IMAGING WITH PD-L1 BINDING POLYPEPTIDES